Rita Casadonte

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 17

Top Topics

Ultra High Performance Liquid Chromatography

Mass Spectrometry

Small Cell Lung Cancer

Top Venues

Proteomics. Clinical applications

International journal of molecular sciences

This page only lists publications with an associated author ORCID identifier.

Publications

Rita Casadonte, Mark Kriegsmann, Katharina Kriegsmann, Helene Streit, Rolf Rüdiger Meliß, Cornelia Sigrid Lissi Müller, Joerg Kriegsmann
Imaging Mass Spectrometry for the Classification of Melanoma Based on BRAF / NRAS Mutational Status. International journal of molecular sciences 24 (6) (2023)
Rita Casadonte, Mark Kriegsmann, Katharina Kriegsmann, Helene Streit, Rolf Rüdiger Meliß, Cornelia Sigrid Lissi Müller, Joerg Kriegsmann
Imaging Mass Spectrometry for the Classification of Melanoma Based on BRAF / NRAS Mutational Status. International journal of molecular sciences 24 (6) (2023)
Rita Casadonte, Jörg Kriegsmann, Mark Kriegsmann, Katharina Kriegsmann, Roberta Torcasio, Maria Eugenia Gallo Cantafio, Giuseppe Viglietto, Nicola Amodio
A Comparison of Different Sample Processing Protocols for MALDI Imaging Mass Spectrometry Analysis of Formalin-Fixed Multiple Myeloma Cells. Cancers 15 (3) (2023)
Rita Casadonte, Jörg Kriegsmann, Mark Kriegsmann, Katharina Kriegsmann, Roberta Torcasio, Maria Eugenia Gallo Cantafio, Giuseppe Viglietto, Nicola Amodio
A Comparison of Different Sample Processing Protocols for MALDI Imaging Mass Spectrometry Analysis of Formalin-Fixed Multiple Myeloma Cells. Cancers 15 (3) (2023)
Rita Casadonte, Mark Kriegsmann, Katharina Kriegsmann, Helene Streit, Rolf Rüdiger Meliß, Cornelia Sigrid Lissi Müller, Joerg Kriegsmann
Imaging Mass Spectrometry for the Classification of Melanoma Based on BRAF / NRAS Mutational Status. International journal of molecular sciences 24 (6) (2023)
Charlotte Janßen, Tobias Boskamp, Jean Le'Clerc Arrastia, Daniel Otero Baguer, Lena Hauberg-Lotte, Mark Kriegsmann, Katharina Kriegsmann, Georg Steinbuß, Rita Casadonte, Jörg Kriegsmann, Peter Maass
Multimodal Lung Cancer Subtyping Using Deep Learning Neural Networks on Whole Slide Tissue Images and MALDI MSI. Cancers 14 (24) (2022)
Charlotte Janßen, Tobias Boskamp, Lena Hauberg-Lotte, Jens Behrmann, Sören-Oliver Deininger, Mark Kriegsmann, Katharina Kriegsmann, Georg Steinbuß, Hauke Winter, Thomas Muley, Rita Casadonte, Jörg Kriegsmann, Peter Maaß
Robust subtyping of non-small cell lung cancer whole sections through MALDI mass spectrometry imaging. Proteomics. Clinical applications 16 (4) (2022)
Charlotte Janßen, Tobias Boskamp, Jean Le'Clerc Arrastia, Daniel Otero Baguer, Lena Hauberg-Lotte, Mark Kriegsmann, Katharina Kriegsmann, Georg Steinbuß, Rita Casadonte, Jörg Kriegsmann, Peter Maass
Multimodal Lung Cancer Subtyping Using Deep Learning Neural Networks on Whole Slide Tissue Images and MALDI MSI. Cancers 14 (24) (2022)
Marina Wierz, Beate Sauerbrei, Petra Wandernoth, Mark Kriegsmann, Rita Casadonte, Katharina Kriegsmann, Jörg Kriegsmann
Detection of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) including Variant Analysis by Mass Spectrometry in Placental Tissue. Viruses 14 (3) (2022)
Rita Casadonte, Mark Kriegsmann, Katharina Kriegsmann, Isabella Hauk, Rolf R Meliß, Cornelia S L Müller, Jörg Kriegsmann
Imaging Mass Spectrometry-Based Proteomic Analysis to Differentiate Melanocytic Nevi and Malignant Melanoma. Cancers 13 (13) (2021)
Mark Kriegsmann, Christiane Zgorzelski, Rita Casadonte, Kristina Schwamborn, Thomas Muley, Hauke Winter, Martin Eichhorn, Florian Eichhorn, Arne Warth, Soeren-Oliver Deininger, Petros Christopoulos, Michael Thomas, Thomas Longerich, Albrecht Stenzinger, Wilko Weichert, Carsten Müller-Tidow, Jörg Kriegsmann, Peter Schirmacher, Katharina Kriegsmann
Mass Spectrometry Imaging for Reliable and Fast Classification of Non-Small Cell Lung Cancer Subtypes. Cancers 12 (9) (2020)
Rémi Longuespée, Rita Casadonte, Kristina Schwamborn, Mark Kriegsmann
Proteomics in Pathology: The Special Issue. Proteomics. Clinical applications 13 (1) (2019)
Alice Ly, Rémi Longuespée, Rita Casadonte, Petra Wandernoth, Kristina Schwamborn, Christine Bollwein, Christian Marsching, Katharina Kriegsmann, Carsten Hopf, Wilko Weichert, Jörg Kriegsmann, Peter Schirmacher, Mark Kriegsmann, Sören-Oliver Deininger
Site-to-Site Reproducibility and Spatial Resolution in MALDI-MSI of Peptides from Formalin-Fixed Paraffin-Embedded Samples. Proteomics. Clinical applications 13 (1) (2019)
Danielle A Scott, Rita Casadonte, Barbara Cardinali, Laura Spruill, Anand S Mehta, Franca Carli, Nicole Simone, Mark Kriegsmann, Lucia Del Mastro, Joerg Kriegsmann, Richard R Drake
Increases in Tumor N-Glycan Polylactosamines Associated with Advanced HER2-Positive and Triple-Negative Breast Cancer Tissues. Proteomics. Clinical applications 13 (1) (2019)
Yovany Cordero Hernandez, Tobias Boskamp, Rita Casadonte, Lena Hauberg-Lotte, Janina Oetjen, Delf Lachmund, Annette Peter, Dennis Trede, Katharina Kriegsmann, Mark Kriegsmann, Jörg Kriegsmann, Peter Maass
Targeted Feature Extraction in MALDI Mass Spectrometry Imaging to Discriminate Proteomic Profiles of Breast and Ovarian Cancer. Proteomics. Clinical applications 13 (1) (2018)
Rita Casadonte, Mark Kriegsmann, Aurel Perren, Gustavo Baretton, Sören-Oliver Deininger, Katharina Kriegsmann, Thilo Welsch, Christian Pilarsky, Jörg Kriegsmann
Development of a Class Prediction Model to Discriminate Pancreatic Ductal Adenocarcinoma from Pancreatic Neuroendocrine Tumor by MALDI Mass Spectrometry Imaging. Proteomics. Clinical applications 13 (1) (2018)
Rémi Longuespée, Katharina Kriegsmann, Martin Cremer, Christiane Zgorzelski, Rita Casadonte, Daniel N Kazdal, Jörg Kriegsmann, Wilko Weichert, Kristina Schwamborn, Margaux Fresnais, Peter Schirmacher, Mark Kriegsmann
In MALDI-Mass Spectrometry Imaging on Formalin-Fixed Paraffin-Embedded Tissue Specimen Section Thickness Significantly Influences m/z Peak Intensity. Proteomics. Clinical applications 13 (1) (2018)